Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Shield Therapeutics PLC 16 April 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Notice of Results Investor...
Shield Therapeutics PLC on Wednesday said that it was expecting stellar results for 2023, but this success was oversh ...
Shield Therapeutics PLC 21 February 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Unaudited Full Year Trading...
cs PLC - Commercial-stage pharmaceutical company focused on iron deficiency product Accrufer - Hires Santosh Shanbhag ...
Shield Therapeutics PLC 09 January 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group"...
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...
Shield Therapeutics PLC 07 December 2023 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Q3 2023...
Shield Therapeutics PLC 27 November 2023 Shield Therapeutics plc ("Shield Therapeutics" or the "Company") PDMR Transaction...
cs PLC - commercial-stage pharmaceutical company focusing on its iron deficiency product Accrufer - Chief Financial Of ...
Shield Therapeutics PLC 12 October 2023 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Chief...
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...
Shield Therapeutics PLC 03 October 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR...
Shield Therapeutics PLC on Tuesday said it has now completed its USD20 million senior secured debt facility from SWK ...
Shield Therapeutics PLC 03 October 2023 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Block...
Shield Therapeutics PLC 03 October 2023 3 October 2023 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지